Abstract
Endoscopic ultrasonography (EUS) is the most sensitive imaging method for diagnosis of pancreatic tumors. However, it still has limits in the differentiation between pancreatic cancers and inflammatory tumor-like masses. A novel technology, contrast-enhanced harmonic EUS (CH-EUS), has been developed recently. It can visualize both parenchymal perfusion and microvasculature in pancreas without Doppler-related artifacts. Therefore, it is superior to EUS and CT in detecting small pancreatic masses and differential diagnosis of pancreatic masses. CH-EUS could be used for adequate sampling of pancreatic tumors and may predict the pathological features of the pancreatic solid lesions but still cannot replace EUS-FNA now.
| Original language | English (US) |
|---|---|
| Article number | 786239 |
| Journal | Diagnostic and Therapeutic Endoscopy |
| DOIs | |
| State | Published - 2012 |
Fingerprint
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Cite this
Contrast-enhanced harmonic endoscopic ultrasonography in pancreatic diseases. / Xu, Can; Li, Zhaoshen; Wallace, Michael.
In: Diagnostic and Therapeutic Endoscopy, 2012.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Contrast-enhanced harmonic endoscopic ultrasonography in pancreatic diseases
AU - Xu, Can
AU - Li, Zhaoshen
AU - Wallace, Michael
PY - 2012
Y1 - 2012
N2 - Endoscopic ultrasonography (EUS) is the most sensitive imaging method for diagnosis of pancreatic tumors. However, it still has limits in the differentiation between pancreatic cancers and inflammatory tumor-like masses. A novel technology, contrast-enhanced harmonic EUS (CH-EUS), has been developed recently. It can visualize both parenchymal perfusion and microvasculature in pancreas without Doppler-related artifacts. Therefore, it is superior to EUS and CT in detecting small pancreatic masses and differential diagnosis of pancreatic masses. CH-EUS could be used for adequate sampling of pancreatic tumors and may predict the pathological features of the pancreatic solid lesions but still cannot replace EUS-FNA now.
AB - Endoscopic ultrasonography (EUS) is the most sensitive imaging method for diagnosis of pancreatic tumors. However, it still has limits in the differentiation between pancreatic cancers and inflammatory tumor-like masses. A novel technology, contrast-enhanced harmonic EUS (CH-EUS), has been developed recently. It can visualize both parenchymal perfusion and microvasculature in pancreas without Doppler-related artifacts. Therefore, it is superior to EUS and CT in detecting small pancreatic masses and differential diagnosis of pancreatic masses. CH-EUS could be used for adequate sampling of pancreatic tumors and may predict the pathological features of the pancreatic solid lesions but still cannot replace EUS-FNA now.
UR - http://www.scopus.com/inward/record.url?scp=84870199897&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870199897&partnerID=8YFLogxK
U2 - 10.1155/2012/786239
DO - 10.1155/2012/786239
M3 - Article
JO - Diagnostic and Therapeutic Endoscopy
JF - Diagnostic and Therapeutic Endoscopy
SN - 1070-3608
M1 - 786239
ER -